Spectral AI Research Partner Using DeepView System Wins Best Research Project at the 2025 Education Awards
Award Recognition: Spectral AI's research partners, RCSI Skin Wounds and Trauma Research Center and RCSI Connolly Hospital, received the Best Research Project award at the 2025 Education Awards for their innovative use of the DeepView System in treating Diabetic Foot Ulcers.
Impact on Wound Care: The DeepView System aims to revolutionize wound care by providing real-time assessments of healing potential, enhancing treatment decisions, and improving patient outcomes while reducing healthcare costs.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on MDAIW

No data
About the author

Spectral AI Secures $7.6 Million in New Growth Funding
Funding Announcement: Spectral AI, Inc. has priced a $7.6 million offering to support the growth and development of its DeepView® System, which focuses on medical diagnostics in wound care.
Share Issuance Details: The offering includes the issuance of 4,000,000 shares of common stock at $1.90 per share, along with corresponding warrants for future exercise.
Company Commitment: Chairman J. Michael DiMaio expressed confidence in securing institutional funding, emphasizing the company's commitment to advancing the DeepView System and supporting its BARDA Project BioShield contract.
About DeepView System: The DeepView System aims to provide clinicians with immediate assessments of burn wounds' healing potential, improving patient outcomes and reducing healthcare costs through algorithm-driven insights.

Spectral AI Recognized in TIME's 2025 List of Leading HealthTech Companies
Recognition of Spectral AI: Spectral AI, Inc. has been named to TIME's World's Top HealthTech Companies 2025 list, highlighting its innovative contributions to medical diagnostics in wound care.
DeepView Technology: The company's DeepView System aims to revolutionize wound management by providing predictive assessments of burn wounds, enhancing treatment decisions and potentially improving patient outcomes while reducing healthcare costs.









